Effects of peripheral administration of ghrelin antagonist [D-Lys<sup>3</sup>]-GHRP-6 on growth performance and blood biochemical indices in broiler chickens
-
Published:2016-02-29
Issue:1
Volume:59
Page:113-119
-
ISSN:2363-9822
-
Container-title:Archives Animal Breeding
-
language:en
-
Short-container-title:Arch. Anim. Breed.
Author:
Aghdam Shahryar Habib,Lotfi Alireza
Abstract
Abstract. In the present study, possible effects of peripheral administration of ghrelin antagonist [D-Lys3]-GHRP-6 on chicken performance, thyroid hormones level and serum biochemical parameters were investigated. Broiler chicks divided into five experimental groups were reared up to day 42. On day 21, a treatment was assigned to the five groups: group 1 (control), chickens without any administration of peptide or solution; group 2 (G50), chickens with intraperitoneal (IP) injection of 50 ng per 100 g body weight (BW) of D-Lys3 peptide on day 21; group 3 (G100), chickens with IP injection of 100 ng per 100 g BW of D-Lys3 peptide on day 21; group 4 (G150), chickens with IP injection of 150 ng per 100 g BW of D-Lys3 peptide on day 21; and group 5 (G200), chickens with IP injection of 200 ng per 100 g BW of D-Lys3 peptide on day 21. On days 21 (post-injection) and 42 (post-rearing), blood samples were obtained from the animals for laboratory analyses. Experimental groups administered the GHS-R antagonist showed less feed intake – i.e., administration of greater doses led to less feed intake (P < 0.01). Daily weight gains within groups G150 and G200 decreased (P < 0.01) in comparison with the control. The feed conversion ratio (FCR) did not differ among the groups. There was a significant difference between control and experimental groups for glucose, total cholesterol and phosphorus levels (P < 0.01) in post-injection samples. In post-injection and post-rearing blood samples, the thyroid hormone (T3 and T4) in 6 h increased in treated groups in comparison with the control (P < 0.01). The infusion of ghrelin antagonist [D-Lys3]-GHRP-6 reduces feed intake and body weight. With regard to increase in T4 level, it can be inferred that [D-Lys3]-GHRP-6 may increase metabolic rate, lipolysis and weight loss, which is similar to results obtained in mammalian species.
Publisher
Copernicus GmbH
Reference33 articles.
1. Aghdam Shahryar, H. and Lotfi, A.: Effect of in ovo ghrelin administration on
thyroid hormones and some of serum biochemical parameters in newly-hatched
chicks, Kafkas Univ. Vet. Fak. Derg., 19, 857–860, 2013. 2. Aghdam Shahryar, H. and Lotfi, A.: Effects of peptidic growth hormone
secretagogue receptor (GHS-R) antagonist [D-Lys3] on some of serum hormonal
and biochemical parameters in Wistar rat model, Arq. Bras. Endocrinol.
Metabol., 58, 288–291, 2014. 3. Asakawa, A., Inui, A., Kaga, T., Katsuura, G., Fujimiya, M., Fujino, M. A.,
and Kasuga, M.: Antagonism of ghrelin receptor reduces food intake and body
weight gain in mice, Gut, 52, 947–952, 2003. 4. Buyse, J., Janssen, S., Geelissen, S., Swennen, Q., Kaiya, H., Darras, V. M.,
and Dridi, S.: Ghrelin modulates fatty acid synthase and related
transcription factor mRNA levels in a tissue-specific manner in neonatal
broiler chicks, Peptides, 30, 1342–1347, 2009. 5. Costantini, V. J., Vicentinim, E., Sabbatini, F. M., Valerio, E., Lepore, S.,
Tessari, M., Sartori, M., Michielin, F., Melotto, S., Bifone, A., Pich, E.
M., and Corsi, M.: GSK1614343, a novel ghrelin receptor antagonist, produces an
unexpected increase of food intake and body weight in rodents and dogs,
Neuroendocrinology, 94, 158–168, 2011.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|